V019-2046 Screening compound: N-({[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]carbamoyl}methyl)-N-(2-methylpropyl)nonanamide

V019-2046 Screening compound: N-({[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]carbamoyl}methyl)-N-(2-methylpropyl)nonanamide
V019-2046 Screening compound: N-({[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]carbamoyl}methyl)-N-(2-methylpropyl)nonanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-2046
N-({[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]carbamoyl}methyl)-N-(2-methylpropyl)nonanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-2046

Molecular Formula

C30H39FN4O2 (C30 H39 FN4 O2)

Compound Name

N-({[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]carbamoyl}methyl)-N-(2-methylpropyl)nonanamide

IUPAC name

N-({[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]carbamoyl}methyl)-N-(2-methylpropyl)nonanamide

SMILES

CCCCCCCCC(N(CC(C)C)CC(Nc1cc(-c2ccccc2)nn1-c(cc1)ccc1F)=O)=O

InChI

InChI=1S/C30H39FN4O2/c1-4-5-6-7-8-12-15-30(37)34(21-23(2)3)22-29(36)32-28-20-27(24-13-10-9-11-14-24)33-35(28)26-18-16-25(31)17-19-26/h9-11,13-14,16-20,23H,4-8,12,15,21-22H2,1-3H3,(H,32,36)

InChI Key

NAOORLHTZUJGQJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19717200

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

506.66

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

16.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

7.830

Distribution Coefficient, logD

7.830

Water Solubility, LogSw

-5.63

Polar Surface Area

53.506

Acid Dissociation Constant (pKa)

13.33

Base Dissociation Constant (pKb)

-1.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.30

V019-2046 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V019-2046 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-2046?
Check Price and Availability of V019-2046, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-2046 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-2046
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-2046
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-2046 available by request